OACC (Oaktree Acquisition III Life Sciences) ROCE %: -0.90% (As of Mar. 2026)


OACC Oaktree Acquisition Corp III Life Sciences OACC
15 GF Score
Price $10.67
View Full Analysis

What is Oaktree Acquisition III Life Sciences ROCE %?

Oaktree Acquisition III Life Sciences OACC -0.28% 15 ROCE % is -0.90% as of Mar. 2026. GuruFocus rates OACC with a GF Score™ of 15/100.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Oaktree Acquisition III Life Sciences's annualized ROCE % for the quarter that ended in Mar. 2026 was -0.90%.

Oaktree Acquisition III Life Sciences  (NAS:OACC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Oaktree Acquisition III Life Sciences ROCE % Related Terms

Oaktree Acquisition III Life Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Oaktree Acquisition III Life Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oaktree Acquisition III Life Sciences ROCE % Chart

Oaktree Acquisition III Life Sciences Annual Data
Trend Dec24 Dec25
ROCE %
0.00 -0.60

Oaktree Acquisition III Life Sciences Quarterly Data
Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial -0.91 -0.55 -0.45 -0.51 -0.90
OACC
15GF Score
Oaktree Acquisition Corp III Life Sciences OACC
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oaktree Acquisition III Life Sciences ROCE % Calculation

Oaktree Acquisition III Life Sciences's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-1.196/( ( (195.251 - 0.727) + (203.112 - 1.3) )/ 2 )
=-1.196/( (194.524+201.812)/ 2 )
=-1.196/198.168
=-0.60 %

Oaktree Acquisition III Life Sciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1.828/( ( (203.112 - 1.3) + (204.83 - 1.624) )/ 2 )
=-1.828/( ( 201.812 + 203.206 )/ 2 )
=-1.828/202.509
=-0.90 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -0.90% mean?
Oaktree Acquisition III Life Sciences (OACC) has a ROCE % of -0.90% as of Mar. 2026.
Is Oaktree Acquisition III Life Sciences' ROCE % too high?
Oaktree Acquisition III Life Sciences' current ROCE % is -0.90%. Overall, Oaktree Acquisition III Life Sciences has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Oaktree Acquisition III Life Sciences' ROCE % compare to RAAQ and FACT?
Oaktree Acquisition III Life Sciences' ROCE % of -0.90% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Diversified Financial Services company?
A good ROCE % depends on the Diversified Financial Services industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Oaktree Acquisition III Life Sciences's current ROCE % is -0.90%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oaktree Acquisition III Life Sciences stock overvalued right now?
Oaktree Acquisition III Life Sciences (OACC) has a current ROCE % of -0.90%. The current ROCE % is -0.90%. Oaktree Acquisition III Life Sciences' overall GF Score™ is 15/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Oaktree Acquisition III Life Sciences (OACC), the current ROCE % is -0.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Oaktree Acquisition III Life Sciences Business Description

Address 333 South Grand Avenue, 28th Floor, Los Angeles, CA, USA, 90071
Oaktree Acquisition Corp III Life Sciences is a blank check company.
15GF Score

Get the complete analysis for OACC

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.67
Price